89bio Organization
89Bio is a biopharmaceutical company building a pipeline of biologic and small molecule treatments for liver and metabolic disorders.
Industry:
PharmTech
Technology:
Data-driven Technologies
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Investors Number:
4
Headquarters:
San Francisco, California, United States
Employee Number:
11-50
Investor Type:
Healthcare Company
Total Funding:
£27M
Founded Date:
2018
Last Funding Type:
Series A